Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 131
interventional 104
Observational 24
Registry 3

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug|placebo 46
Device 15
Drug 15
Procedure 10
Other 6
Device|Other 2
Dietary Supplement 2
Other|Procedure 2
Behavioral 1
Biological 1
Biological|Dietary Supplement|Other|Radiation 1
Device|Procedure 1
Diagnostic Test 1
Drug|Other 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 55
Australia 5
Belgium 3
Canada 3
Korea, Republic of 3
NA 3
United Kingdom 3
France 2
Sweden 2
Australia|Germany|Sweden|United Kingdom 1
Austria 1
Belgium|Sweden 1
China 1
Czechia 1
Denmark 1
Denmark|Sweden 1
Germany 1
India 1
Japan 1
Malaysia 1
Mexico 1
Philippines|Denmark|France|United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Colombia|Germany|Hungary|India|Israel|Korea, Republic of|Latvia|Malaysia|Mexico|Poland|Romania|Russian Federation|Singapore|South Africa|Spain|Thailand|Ukraine|United Kingdom 1
Poland|United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Colombia|Denmark|France|Germany|Hungary|India|Israel|Italy|Korea, Republic of|Latvia|Malaysia|Mexico|Philippines|Romania|Russian Federation|Singapore|South Africa|Spain|Thailand|Ukraine|United Kingdom 1
South Africa|United States|Argentina|Austria|Belgium|Brazil|Canada|Colombia|Denmark|Germany|Hungary|Latvia|Mexico|Puerto Rico|Romania|Russian Federation|Ukraine|United Kingdom 1
Switzerland 1
United States|Australia|Belgium|Canada|Sweden|United Kingdom 1
United States|Australia|Bulgaria|France|India|Israel|Italy|Korea, Republic of|Malaysia|Philippines|Poland|Singapore|Spain|Thailand|Ukraine 1
United States|Belgium|Czechia|Denmark|Germany|Netherlands|Romania|Slovakia|Sweden|United Kingdom 1
United States|Belgium|Denmark|Finland|Germany|Norway|Poland|Sweden 1
United States|Belgium|Germany|Israel|Poland|Sweden|United Kingdom 1
United States|Belgium|Italy|Japan|Poland 1
United States|Canada|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Colombia|Denmark|France|Germany|Hungary|India|Israel|Italy|Korea, Republic of|Latvia|Malaysia|Mexico|Philippines|Poland|Puerto Rico|Romania|Russian Federation|Saudi Arabia|Singapore|South Africa|Spain|Thailand|Ukraine|United Kingdom 1
United States|Denmark|India|Norway|Sweden|United Kingdom 1
United States|Denmark|Norway|Poland|Sweden|United Kingdom 1

Sites per Study

Site_count Study_Count
1 65
2 5
3 1
5 1
6 2
7 2
8 2
9 2
11 1
12 2
14 1
19 1
20 1
21 1
22 1
23 1
24 1
30 1
34 1
49 1
50 1
52 1
65 1
67 1
98 1
115 1
300 1
334 1
472 1
486 1
620 1

Phase

Phase Study_Count
N/A 39
Phase 2 33
Phase 1 12
Phase 3 11
Early Phase 1 4
Phase 1/Phase 2 3
Phase 2/Phase 3 1
Phase 4 1

Number of Arms

Number_of_Arms Count_of_Studies
1 20
2 57
3 7
4 12
5 1
6 2
7 1
10 1
NA 3

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 10.0 3.00000 6.00 20.00000 2.00 15 53.0000 12
1st Qu. 11.5 20.50000 9.50 22.50000 34.00 15 165.0000 12
Median 26.0 38.00000 18.50 25.00000 69.00 15 250.0000 12
Mean 28.0 56.15789 22.00 41.66667 97.75 15 423.2727 12
3rd Qu. 42.5 74.25000 27.25 52.50000 116.00 15 600.0000 12
Max. 50.0 220.00000 51.00 80.00000 393.00 15 1000.0000 12

Trial Group Type

group_type Group_Count
Experimental 123
Placebo Comparator 48
Active Comparator 44
Other 12
Sham Comparator 6
No Intervention 4
NA 3

Intervention Model

intervention_model Study_Count
Parallel Assignment 55
Single Group Assignment 24
Crossover Assignment 21
Sequential Assignment 3
NA 1

Primary Purpose

primary_purpose Study_Count
Treatment 80
Diagnostic 8
Prevention 7
Basic Science 3
NA 3
Health Services Research 1
Other 1
Supportive Care 1

Observational Studies

Studies by Country

Country Study_Count
United States 15
France 3
NA 3
Korea, Republic of 2
Ireland 1

Sites per Study

Site_count Study_Count
1 15
2 2
3 1
4 1
6 2
7 3

Enrollment Metrics

Measure Observational
Min 3.0000
1st Qu 38.0000
Median 67.5000
Mean 267.2917
3rd Qu 211.0000
Max 3000.0000

Observation Model

observational_model Study_Count
Cohort 13
Case-Only 5
Case Control 3
Other 2
Case-Control 1

Time Perspective

time_perspective Study_Count
Prospective 19
Other 2
Retrospective 2
Cross-Sectional 1

Registries

Studies by Country

Country Study_Count
United States 3

Sites per Study

Site_count Study_Count
1 3

Enrollment Metrics

Measure Registries
Min 200.0000
1st Qu 200.0000
Median 200.0000
Mean 216.6667
3rd Qu 225.0000
Max 250.0000

Registry Model

observational_model Study_Count
Case-Control 1
Case-Only 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 3

Follow-up

target_duration Study_Count
2 Years 3

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04418739 Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes https://ClinicalTrials.gov/show/NCT04418739 Recruiting Universiti Kebangsaan Malaysia Medical Centre 2021-11-26
NCT03383146 A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04 https://ClinicalTrials.gov/show/NCT03383146 Active, not recruiting Allergan 2021-07-29
NCT03294616 Transcutaneous Electroacupuncture for Gastric Complications of Scleroderma https://ClinicalTrials.gov/show/NCT03294616 Completed Johns Hopkins University 2019-06-30
NCT03285308 A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01 https://ClinicalTrials.gov/show/NCT03285308 Active, not recruiting Allergan 2021-09-21
NCT03281577 Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants https://ClinicalTrials.gov/show/NCT03281577 Completed Takeda 2019-07-12
NCT03268941 A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG) https://ClinicalTrials.gov/show/NCT03268941 Completed Takeda 2018-03-09
NCT03176927 Biomagnetic Characterization of Gastric Dysrhythmias III https://ClinicalTrials.gov/show/NCT03176927 Enrolling by invitation Vanderbilt University Medical Center 2020-08-31
NCT03126513 Gastric Per Oral Endoscopic Myotomy (G-POEM) in Refractory Gastroparesis https://ClinicalTrials.gov/show/NCT03126513 Completed Coordinación de Investigación en Salud, Mexico 2018-09-01
NCT03123809 Gastric Electrical Stimulation (GES) and Pyloroplasty for the Treatment of Gastroparesis https://ClinicalTrials.gov/show/NCT03123809 Recruiting Texas Tech University Health Sciences Center, El Paso 2020-05-15
NCT03120325 Vagal Nerve Stimulation for Gastroparesis https://ClinicalTrials.gov/show/NCT03120325 Recruiting Stanford University 2020-03-01
NCT03036891 Naloxegol for Opioid-Related Gastroparesis https://ClinicalTrials.gov/show/NCT03036891 Recruiting Temple University 2020-01-30
NCT02838797 RQ-00000010 for Gastroparesis and Constipation in Parkinson’s Disease https://ClinicalTrials.gov/show/NCT02838797 Completed Virginia Commonwealth University 2019-08-20
NCT02779920 Feasibility of Endoscopic Pylorotomy in the Treatment of Refractory Gastroparesis, Pilot Study. https://ClinicalTrials.gov/show/NCT02779920 Completed University Hospital, Limoges 2017-06-30
NCT02736799 Effect of Vibrant Capsule on Gastric Emptying and Antropyloroduodenal Motility in Healthy Volunteers https://ClinicalTrials.gov/show/NCT02736799 Completed Vibrant Ltd. 2016-12-31
NCT02635399 Impact of Additional DJ (Duodenojejunostomy)-Pexy on Reduction in Delayed Gastric Emptying Following Pylorus-preserving Pancreaticoduodenectomy: A Prospective, Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT02635399 Recruiting Yonsei University 2019-12-31
NCT02025751 Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis https://ClinicalTrials.gov/show/NCT02025751 Completed Evoke Pharma 2016-08-31
NCT02025725 Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis https://ClinicalTrials.gov/show/NCT02025725 Completed Evoke Pharma 2016-05-27
NCT02031081 Prucalopride Versus Placebo in Gastroparesis https://ClinicalTrials.gov/show/NCT02031081 Completed University of Calgary 2018-06-30
NCT02447237 Randomized Trial:the Effect of Liquid Food on the Intake of Energy and Protein in Malignant Hematologic Patients https://ClinicalTrials.gov/show/NCT02447237 Completed University of Copenhagen 2015-07-31
NCT02397577 Reference Values for Gastric Emptying https://ClinicalTrials.gov/show/NCT02397577 Completed University of Zurich 2018-05-01
NCT02357420 Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis https://ClinicalTrials.gov/show/NCT02357420 Completed Allergan 2016-06-09
NCT02324010 Effects of Sitagliptin on Gastric Emptying, Glycaemia and Blood Pressure in Type 2 Diabetes https://ClinicalTrials.gov/show/NCT02324010 Completed Royal Adelaide Hospital 2017-01-31
NCT02289846 Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP) https://ClinicalTrials.gov/show/NCT02289846 Completed Ironwood Pharmaceuticals, Inc. 2015-12-31
NCT02267525 The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study https://ClinicalTrials.gov/show/NCT02267525 Completed Theravance Biopharma 2017-06-30
NCT02232308 Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects https://ClinicalTrials.gov/show/NCT02232308 Completed Mayo Clinic 2014-09-30
NCT02210000 A Study to Evaluate the Effect of Camicinal on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects With Gastroparesis https://ClinicalTrials.gov/show/NCT02210000 Completed GlaxoSmithKline 2015-08-24
NCT02187094 Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis https://ClinicalTrials.gov/show/NCT02187094 Completed Targacept Inc. 2015-01-31
NCT02086461 Pylorus Dysfunction After Esophagectomy and Gastric Tube Reconstruction. Effect of Pneumatic Pylorus Dilatation During Hospital Stay, Surgical Complications During in Hospital Stay https://ClinicalTrials.gov/show/NCT02086461 Enrolling by invitation Karolinska University Hospital 2020-12-31
NCT01294566 FTIH to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of GSK1322888 in Healthy Caucasian and Japanese Volunteers https://ClinicalTrials.gov/show/NCT01294566 Completed GlaxoSmithKline 2011-03-23
NCT03356067 Endoscopic Pyloromyotomy for Refractory Gastroparesis https://ClinicalTrials.gov/show/NCT03356067 Recruiting Institute for Clinical and Experimental Medicine 2021-06-01
NCT01919021 Assessment of Gastro-Intestinal Function to a Mixed Meal by Non-invasive Imaging https://ClinicalTrials.gov/show/NCT01919021 Completed Nottingham University Hospitals NHS Trust 2014-04-30
NCT01916460 Intraluminal Endosonography for Examination of the Structural Changes of the Stomach in Gastroparetic Patients https://ClinicalTrials.gov/show/NCT01916460 Completed Texas Tech University Health Sciences Center, El Paso 2014-09-30
NCT01787955 Impact of Braun Anastomosis on Reduction in Delayed Gastric Emptying Following Pancreaticoduodenectomy https://ClinicalTrials.gov/show/NCT01787955 Completed Yonsei University 2014-08-31
NCT01718938 Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis https://ClinicalTrials.gov/show/NCT01718938 Completed Theravance Biopharma 2013-12-31
NCT01711918 Domperidone for the Treatment of Chronic Nausea and Vomiting Secondary to Gastroparesis https://ClinicalTrials.gov/show/NCT01711918 Completed University of Iowa 2014-04-30
NCT01696734 Domperidone in Treating Patients With Gastrointestinal Disorders https://ClinicalTrials.gov/show/NCT01696734 Recruiting M.D. Anderson Cancer Center 2021-10-31
NCT01659619 Effect of Erythromycin Before Endoscopy of Patients With Subtotal Gastrectomy (STG), High Risk of Gastric Stasis https://ClinicalTrials.gov/show/NCT01659619 Completed The Catholic University of Korea 2012-10-31
NCT01650714 Endoscopic Full Thickness Biopsy, Gastric Wall. https://ClinicalTrials.gov/show/NCT01650714 Completed Mayo Clinic 2014-09-30
NCT01643577 Acupuncture Treatment for Gastroparesis: a Pilot Study https://ClinicalTrials.gov/show/NCT01643577 Completed Johns Hopkins University 2013-11-30
NCT01607684 Pilot Study to Evaluate Magnetic Marker Imaging on Diabetic Polyneuropathy and Gastroparesis https://ClinicalTrials.gov/show/NCT01607684 Completed Martin-Luther-Universität Halle-Wittenberg 2012-09-30
NCT01602549 A Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson’s Disease Exhibiting Delayed Gastric Emptying https://ClinicalTrials.gov/show/NCT01602549 Completed GlaxoSmithKline 2014-05-31
NCT01571297 Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis https://ClinicalTrials.gov/show/NCT01571297 Completed Motus Therapeutics, Inc. 2013-08-31
NCT01557296 Evaluation of Diagnostic Methods and Dietary Treatment of Diabetic Gastroparesis https://ClinicalTrials.gov/show/NCT01557296 Completed Göteborg University 2014-03-31
NCT01469286 Transcutaneous Electroacupuncture for Gastroparesis https://ClinicalTrials.gov/show/NCT01469286 Completed Transtimulation Research, Inc 2012-07-31
NCT01452815 Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis https://ClinicalTrials.gov/show/NCT01452815 Completed Tranzyme, Inc. 2012-11-30
NCT01394055 Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis https://ClinicalTrials.gov/show/NCT01394055 Completed Motus Therapeutics, Inc. 2012-11-30
NCT04300127 Pioglitazone for Idiopathic Gastroparesis https://ClinicalTrials.gov/show/NCT04300127 Recruiting Johns Hopkins University 2020-09-29
NCT04287647 Transpyloric Stenting as a Predictor for G-POEM for Refractory Gastroparesis https://ClinicalTrials.gov/show/NCT04287647 Recruiting Northwestern University 2022-01-01
NCT04282317 Magnetic Resonance Imaging of the Brain and Stomach in Healthy Volunteers and Gastroparesis https://ClinicalTrials.gov/show/NCT04282317 Recruiting Indiana University 2022-12-31
NCT04254549 Rifaximin in Patients With Diabetic Gastroparesis https://ClinicalTrials.gov/show/NCT04254549 Recruiting Mayo Clinic 2020-06-14
NCT04118881 Ear Acupuncture Preventing Delayed Gastric Emptying. https://ClinicalTrials.gov/show/NCT04118881 Recruiting Tianjin Medical University Cancer Institute and Hospital 2021-08-02
NCT04028492 Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis https://ClinicalTrials.gov/show/NCT04028492 Recruiting Vanda Pharmaceuticals 2020-07-31
NCT04026997 A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis https://ClinicalTrials.gov/show/NCT04026997 Recruiting CinDome Pharma, Inc. 2020-06-30
NCT03987672 Study to Intervene With Nutrition for Gastroparesis https://ClinicalTrials.gov/show/NCT03987672 Recruiting Stanford University 2021-05-30
NCT03984734 Quality of Life and Nutritional Status After Two Surgical Techniques in Pancreatoduodenectomy https://ClinicalTrials.gov/show/NCT03984734 Completed Hospital Universitari de Bellvitge 2008-08-31
NCT03941288 Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia https://ClinicalTrials.gov/show/NCT03941288 Recruiting Mayo Clinic 2024-06-30
NCT03900325 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Exploratory Efficacy of Nimacimab in Patients With Diabetic Gastroparesis https://ClinicalTrials.gov/show/NCT03900325 Active, not recruiting Bird Rock Bio, Inc. 2020-01-31
NCT03810287 The Use Of Domperidone For The Relief Of Refractory Upper Gastrointestinal GI Symptoms https://ClinicalTrials.gov/show/NCT03810287 Recruiting Yale University 2020-06-30
NCT03786380 Diabetic Gastroparesis Study 05 https://ClinicalTrials.gov/show/NCT03786380 Active, not recruiting Allergan 2024-09-30
NCT03712124 A Study of CNSA-001 in Women With Diabetic Gastroparesis https://ClinicalTrials.gov/show/NCT03712124 Completed Censa Pharmaceuticals, Inc. 2019-09-08
NCT03679104 Endoscopic Clips Versus Overstich Suturing System Device for Closure of Mucosotomy After G-POEM https://ClinicalTrials.gov/show/NCT03679104 Recruiting Institute for Clinical and Experimental Medicine 2021-08-11
NCT03603730 Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis https://ClinicalTrials.gov/show/NCT03603730 Recruiting Massachusetts General Hospital 2020-09-30
NCT03587142 Buspirone for Early Satiety and Symptoms of Gastroparesis https://ClinicalTrials.gov/show/NCT03587142 Recruiting National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2021-06-30
NCT03544229 A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis https://ClinicalTrials.gov/show/NCT03544229 Active, not recruiting Takeda 2020-08-07
NCT03531450 Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients https://ClinicalTrials.gov/show/NCT03531450 Recruiting Massachusetts General Hospital 2020-05-08
NCT03512145 Clinical Evaluation of the VIPUN Balloon Catheter 0.2 in Critically Ill Patients https://ClinicalTrials.gov/show/NCT03512145 Completed Universitaire Ziekenhuizen Leuven 2019-08-01
NCT03500354 Nutritional Drink in Gastroparesis https://ClinicalTrials.gov/show/NCT03500354 Recruiting Johns Hopkins University 2020-12-31
NCT03441230 Determination of the Characteristics of Isometric Gastric Motility Measurement in Healthy Volunteers https://ClinicalTrials.gov/show/NCT03441230 Completed Universitaire Ziekenhuizen Leuven 2017-01-20
NCT03426345 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02 https://ClinicalTrials.gov/show/NCT03426345 Active, not recruiting Allergan 2021-09-21
NCT03420781 A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03 https://ClinicalTrials.gov/show/NCT03420781 Enrolling by invitation Allergan 2022-08-09
NCT01267071 A Study to Evaluate the Pharmacokinetics and Absolute Bioavailability of GSK962040 Given as an Oral Dose Simultaneously With an Intravenous Microtracer Dose of [14C]-GSK962040 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT01267071 Completed GlaxoSmithKline 2010-09-01
NCT01262898 Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis https://ClinicalTrials.gov/show/NCT01262898 Completed GlaxoSmithKline 2013-02-26
NCT01248663 Reconstruction Method and Delayed Gastric Emptying After Pancreatic Surgery https://ClinicalTrials.gov/show/NCT01248663 Completed Medical University of Vienna 2009-11-30
NCT01206582 A Pilot Study of Hemin Therapy for Gastroparesis (Diabetes Mellitus) https://ClinicalTrials.gov/show/NCT01206582 Completed Mayo Clinic 2014-12-31
NCT01191138 Gastric Emptying After Infracolic or Supracolic Gastrojejunostomy Following Pancreaticoduodenectomy https://ClinicalTrials.gov/show/NCT01191138 Completed Asian Institute of Gastroenterology, India 2012-02-29
NCT01149369 Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial https://ClinicalTrials.gov/show/NCT01149369 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2015-08-31
NCT01135186 Impact of KUVAN® on Gastric Relaxation in Women With Diabetic Gastroparesis. https://ClinicalTrials.gov/show/NCT01135186 Completed Stanford University 2012-11-30
NCT01126034 Improving Metoclopramide Prescribing Practices at Penn Through a Physician-targeted Intervention https://ClinicalTrials.gov/show/NCT01126034 Completed University of Pennsylvania 2008-04-30
NCT01074710 Safety and Pharmacokinetic Study of C13-URA in Healthy Volunteers https://ClinicalTrials.gov/show/NCT01074710 Completed Otsuka Pharmaceutical Co., Ltd. 2010-05-31
NCT01054794 Temporary Gastric Electrical Stimulation for Gastroparesis https://ClinicalTrials.gov/show/NCT01054794 Completed University of Calgary 2011-12-31
NCT01039974 GSK962040 Drug-drug Interaction Study With Ketoconazole https://ClinicalTrials.gov/show/NCT01039974 Completed GlaxoSmithKline 2009-11-30
NCT01039805 Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed Intolerance https://ClinicalTrials.gov/show/NCT01039805 Completed GlaxoSmithKline 2011-07-31
NCT01030341 Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis https://ClinicalTrials.gov/show/NCT01030341 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2014-11-30
NCT00903799 Medico-economic Evaluation of ENTERRA Therapy https://ClinicalTrials.gov/show/NCT00903799 Completed University Hospital, Rouen 2014-10-31
NCT00889486 Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus https://ClinicalTrials.gov/show/NCT00889486 Completed Tranzyme, Inc. 2010-04-30
NCT00861809 The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With Gastroparesis https://ClinicalTrials.gov/show/NCT00861809 Completed GlaxoSmithKline 2010-11-30
NCT00845858 Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis https://ClinicalTrials.gov/show/NCT00845858 Completed Evoke Pharma 2011-12-31
NCT01467765 The Effect of Elemental Diet on Gastric Emptying https://ClinicalTrials.gov/show/NCT01467765 Completed Showa Inan General Hospital 2012-04-30
NCT00776360 The Effect of Oxytocin on the Gastric Emptying https://ClinicalTrials.gov/show/NCT00776360 Completed Skane University Hospital 2009-12-31
NCT00765895 Nortriptyline for Idiopathic Gastroparesis https://ClinicalTrials.gov/show/NCT00765895 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2012-10-31
NCT00733551 Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects. https://ClinicalTrials.gov/show/NCT00733551 Completed GlaxoSmithKline 2009-07-20
NCT00639808 Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis https://ClinicalTrials.gov/show/NCT00639808 Completed Tranzyme, Inc. 2007-07-31
NCT00612014 Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis https://ClinicalTrials.gov/show/NCT00612014 Completed Tranzyme, Inc. 2009-02-28
NCT00595621 Multi-Channel Gastric Electrical Stimulation for the Treatment of Gastroparesis https://ClinicalTrials.gov/show/NCT00595621 Completed University of Kansas Medical Center 2009-06-30
NCT00568373 Gastric Pacemaker Implantation for Gastroparesis https://ClinicalTrials.gov/show/NCT00568373 Recruiting Indiana University 2020-12-31
NCT00562848 A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040 https://ClinicalTrials.gov/show/NCT00562848 Completed GlaxoSmithKline 2008-06-27
NCT00501657 Effects of Sitagliptin on Gastric Emptying in Healthy Subjects https://ClinicalTrials.gov/show/NCT00501657 Completed Royal Adelaide Hospital 2008-06-30
NCT00492622 Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis https://ClinicalTrials.gov/show/NCT00492622 Completed University of Louisville 2008-12-31
NCT00432835 Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis https://ClinicalTrials.gov/show/NCT00432835 Completed University of Mississippi Medical Center 2006-10-31
NCT00372970 Placebo Controlled Trial of Botulinum Toxin for Gastroparesis https://ClinicalTrials.gov/show/NCT00372970 Completed Temple University 2008-12-31
NCT00370084 Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia https://ClinicalTrials.gov/show/NCT00370084 Completed Forest Laboratories 2006-05-31
NCT00139893 A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis https://ClinicalTrials.gov/show/NCT00139893 Completed UCB Pharma 2005-10-31
NCT00050882 Safety and Effectiveness of an Investigational Agent (GM-611) in Patients With Diabetic Gastroparesis https://ClinicalTrials.gov/show/NCT00050882 Completed Chugai Pharma USA NA
NCT00050609 Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying https://ClinicalTrials.gov/show/NCT00050609 Completed Eli Lilly and Company NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03259841 Ultrasound Assessment of Gastric Contents in Fasted Patient Undergoing Cholecystectomy https://ClinicalTrials.gov/show/NCT03259841 Completed SMG-SNU Boramae Medical Center 2019-02-08
NCT03011151 Protease Activated Receptor-2 and Gastrointestinal Dysfunction in Critical Illness https://ClinicalTrials.gov/show/NCT03011151 Recruiting Boston Children’s Hospital 2020-12-31
NCT02753010 Gastric Emptying in Elderly With Hip Fracture https://ClinicalTrials.gov/show/NCT02753010 Completed Uppsala University 2016-03-31
NCT02732821 G-POEM for Treatment of Refractory Gastroparesis https://ClinicalTrials.gov/show/NCT02732821 Recruiting Johns Hopkins University 2020-07-31
NCT02524496 Limited Access Protocol for the Use of Oral Cisapride https://ClinicalTrials.gov/show/NCT02524496 Completed Yale University 2011-03-31
NCT01316484 Patient Understanding (Cognitive Debriefing) of a Daily Diary of Gastroparesis Symptoms https://ClinicalTrials.gov/show/NCT01316484 Completed Tranzyme, Inc. 2011-04-30
NCT01519180 Antro-pyloro-duodenal Motility in Idiopathic Gastroparesis https://ClinicalTrials.gov/show/NCT01519180 Completed University Hospital, Rouen 2014-01-31
NCT04434781 Gastric Per-Oral Endoscopic Myotomy (G-POEM) for the Treatment of Gastroparesis https://ClinicalTrials.gov/show/NCT04434781 Recruiting Indiana University 2024-08-15
NCT04208828 IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy https://ClinicalTrials.gov/show/NCT04208828 Recruiting University of Louisville 2023-01-02
NCT04207996 Vagus Nerve Response in Gastroparesis Patients https://ClinicalTrials.gov/show/NCT04207996 Recruiting Indiana University 2022-08-31
NCT04121325 Gastric Electrical Stimulation for Abdominal Pain in Gastroparesis https://ClinicalTrials.gov/show/NCT04121325 Recruiting University of Louisville 2020-04-01
NCT04024709 Long-term Results of Per-oral Pyloromyotomy for Refractory Gastroparesis https://ClinicalTrials.gov/show/NCT04024709 Completed University Hospital, Limoges 2019-04-01
NCT03896126 GI-Challenge Study for Gastroparesis Patients and Healthy Controls https://ClinicalTrials.gov/show/NCT03896126 Recruiting Stanford University 2021-01-01
NCT03802006 Ultrasound Assessment of Gastric Contents in Fasted Surgical Patients With Previous Subtotal Gastrectomy https://ClinicalTrials.gov/show/NCT03802006 Recruiting Seoul National University Hospital 2020-11-15
NCT03734627 Gastrointestinal Nutrient Transit and Enteroendocrine Function After Upper Gastrointestinal Surgery https://ClinicalTrials.gov/show/NCT03734627 Enrolling by invitation St. James’s Hospital, Ireland 2021-07-01
NCT03680859 Gastroparesis Registry 3 https://ClinicalTrials.gov/show/NCT03680859 Recruiting National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2021-08-30
NCT03680820 Pediatric Gastroparesis Registry https://ClinicalTrials.gov/show/NCT03680820 Recruiting National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2022-10-30
NCT03525067 Colonization of Bile Ducts and Postoperative Infectious Complications of Pancreaticoduodenectomies https://ClinicalTrials.gov/show/NCT03525067 Completed Central Hospital, Nancy, France 2018-02-01
NCT01696747 Gastroparesis Registry 2 https://ClinicalTrials.gov/show/NCT01696747 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2019-04-30
NCT03178370 Autonomic and Enteric Profiling https://ClinicalTrials.gov/show/NCT03178370 Active, not recruiting University of Louisville 2019-12-31
NCT03876288 Gastroparesis Outcome Longitudinal Database Enrolled Numerically https://ClinicalTrials.gov/show/NCT03876288 Recruiting University of Louisville 2023-01-01
NCT00682877 A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time - Over 65 Years Old https://ClinicalTrials.gov/show/NCT00682877 Completed The SmartPill Corporation 2007-10-31
NCT00398801 Gastroparesis Registry https://ClinicalTrials.gov/show/NCT00398801 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2010-03-31
NCT00128284 A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time https://ClinicalTrials.gov/show/NCT00128284 Completed The SmartPill Corporation 2005-10-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02165059 GI Neuromuscular Pathology Prospective Registry https://ClinicalTrials.gov/show/NCT02165059 Recruiting Indiana University 2020-12-31
NCT02159586 Cardiac Vagal Effects of GES in Patients With Gastroparesis and Vagal Nerve Action Potentials in Vagus Nerve https://ClinicalTrials.gov/show/NCT02159586 Enrolling by invitation Indiana University 2020-12-31
NCT03626350 Prospective Evaluation of the Efficacy and Safety of Submucosal Endoscopy https://ClinicalTrials.gov/show/NCT03626350 Enrolling by invitation University of Colorado, Denver 2023-06-12